Abstract 1057: Mutation of EZH2 A677 in human B-cell lymphoma promotes hyper-trimethylation of H3K27
Michael T. McCabe(GlaxoSmithKline (United States)), Caretha L. Creasy, Edward Dul(GlaxoSmithKline (United States)), Wendy S. Halsey(GlaxoSmithKline (United States)), Sharad K. Verma(GlaxoSmithKline (United States)), Melissa B. Pappalardi(GlaxoSmithKline (United States)), Anthony Della-Pietra(GlaxoSmithKline (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Elsie Diaz(Johnson & Johnson (United States)), Heidi M. Ott(GlaxoSmithKline (United Kingdom)), Sara H. Thrall(GlaxoSmithKline (United States)), Kimberly N. Smitheman(GlaxoSmithKline (United States)), Ashley M. Hughes(GlaxoSmithKline (United States)), Ryan G. Kruger(Arysta LifeScience (France)), Stephanie Chen(Rutgers, The State University of New Jersey), Yong Jiang(GlaxoSmithKline (United States)), Benjamin Schwartz, Gopinath Ganji(GlaxoSmithKline (United States)), Martín Brandt(SINTEF), Kimberly E. Allen(GlaxoSmithKline (United States)), Alan P. Graves(GlaxoSmithKline (United States))
Cited by 1
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848